HBI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Harvard Bioscience Inc

Watchlist Manager

Watchlist

Price: 4.08 EUR Market Closed

Market Cap: €177.2m

H	Harvard Bioscience Inc F:HBI	US
	SRT Marine Systems PLC F:6S7	UK
S	Swire Pacific Ltd OTC:SWRAF	HK
	F5 Inc NASDAQ:FFIV	US
J	Juniper Networks Inc F:JNP	US
D	Deutsche Boerse AG XHAM:DB1	DE
H	HEICO Corp NYSE:HEI.A	US
	Metso Outotec Corp OTC:OUKPY	FI
C	China Coal Energy Co Ltd XMUN:CVV	CN
	Neway CNC Equipment Suzhou Co Ltd SSE:688697	CN
N	Nestle SA XMUN:NESR	CH
	Datatec Ltd F:DTT	ZA
	Brown-Forman Corp F:BF5A	US

Profitability Summary

Harvard Bioscience Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Strong 3Y Average Gross Margin

58%

Gross Margin is Increasing

55% > 58%

Low Operating Margin

Negative 3Y Average Operating Margin

-2%

Operating Margin is Increasing

-2% > 0%

Negative Net Margin

-12%

Negative 3Y Average Net Margin

-28%

Declining Net Margin

-5% > -12%

Negative Free Cash Flow Margin

-2%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

6% > -2%

Negative ROE

-90%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-1% > 1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.